General inactivation of the RB1 pathway and deregulation of the cell cycle was a common early event in human cancers [69, 70], however homozygous deletion of RB1 is a relatively late-stage genomic alteration in acinar prostate cancer progression [68]. The gene discussed is RB1; the disease is cancer.